Southern Illinois University School of Medicine

Current academic appointments at SIU

• Professor of Clinical Psychiatry
  
• Professor of Clinical Pediatrics
  
• Professor of Clinical Neurology
  

  Other appointments

• Medical Director and Chief, Bureau of Clinical Services, Developmental Disabilities Division, Illinois Department of Mental Health & Developmental Disabilities,Springfield, IL

  Education and training

• B.A. in Chemistry (Cum Laude) - Washington and Jefferson College, Washington, Pennsylvania
  
• M.D. - Jefferson Medical College of Thomas Jefferson University,Philadelphia, Pennsylvania
  
• Internship and Residency in Pediatrics - Children's Hospital National Medical Center, Washington, D.C.
  
• Clinical Fellow and Chief Resident in Pediatric Neurology - Duke University Medical Center, Durham, NC

  Honors and Awards

• Letter of Commendation, Commanding General, Camp LeJeune Marine Corps Base, 1991
  
• Command Letter of Appreciation, Naval Hospital Camp LeJeune, N.C., 1991
  
• Certificate of Appreciation, North Carolina Epilepsy Society, 1987 Navy Commendation Medal, 1984
  
• Meritorious Service Award, Uniformed Services University of the Health Sciences, 1984
  
• Command Letter of Appreciation, Naval Regional Medical Center, Camp Pendleton, California, 1979
  
• American Academy of Family Practice Recognition Award, 1979 Letter of Commendation, Naval Regional Medical Center, Camp Pendleton, California, 1979
  
• Resident Award, Best Teacher in Subspecialty, Camp Pendleton, California, 1979
  
• Special Appreciation for Overall Teaching Award, Camp Pendleton, 1979
  
• Chi Epsilon Mu, National Honorary Chemistry Fraternity, 1967
  
• National Merit Scholar, 1964
  

  Certifications

• Pediatrics; American Board of Pediatrics
  
• Neurology with Special Competence in Pediatric Neurology; American Board of Psychiatry and Neurology
  

  Clinical Interests

  Epilepsy, Developmental Disabilities
  

  Research Interests

• Epilepsy, Developmental Disabilities
  
• Use of Telemedicine in a Rural Residential Developmental Center, Collaborator with Illinois Department of Mental health and Developmental Disabilities and Southern Illinois University School of Medicine
• Higher Cortical Function in Childhood, especially neurobiologic correlates of behavior, language, and attention in right hemispheric dysfunction
  
• Childhood Epilepsies, especially drug trials and new drug investigation
  
• Hematologic and Biochemical bases of valproic acid toxicity
  

  Publications

• Sunder TR. Moyamoya Disease. Arch Neurol 1979;36:59-60. (Letter)
  
• Sunder TR, Erwin CW, Dubois PJ. An Unusual Electroencephalographic Finding in Cerebrovascular Moyamoya Disease in Children. EEG Clin Neurophys 1980;49:414-420.
  
• Sunder TR. Seizures in Children. GPO 868-607, Washington, D.C., 1980.
  
• Wilfert CM, O'Quinn A, Sunder TR, Thompson RJ, Zeller J., Blacharsh J. Longitudinal Assessment of Children with Enteroviral Meningitis During the First Three Months of Life. Pediatrics 1981;67:811-815.
  
• Armbrustmacher V, Sunder TR. Case for diagnosis: Muscle Carnitine Deficiency. Mil Med 1981;146:885-889.
  
• Sunder TR. Moyamoya Disease in a Patient with Type I Glycogenesis. Arch Neurol 1981;38:251-253.
  
• Sunder TR. Antenatal Treatment of Hydrocephalus. N Engl J Med 1981;305:403. (Letter)
  
• Sunder TR, Blasam M, Vengrow M. Recurrent Encephalopathy and Angioedema: Report of Two Cases and Review of Literature. JAMA 1982;247:2007.
  
• Sunder TR. On the Danger of Mandated Generics. NCMJ 1988;49:224. (Letter)
  
• Ganick D, Sunder TS, Finley JL. Severe Hematologic Toxicity of Valproic Acid: A Report of Four Patients. Am J. of Ped Hemat/Onc 1990;12:80-85.
  
• Ashwal S, Bale JF Jr, Coulter DL, Eiben R, Garg BP, Hill A, Meyer EC, Nordgren RE, Shewmon DA, Sunder TR, Walker RW (the CNS Ethics Committee). The Persistent Vegetative State in Children: Report of the Child Neurology Society Ethics Committee, Ann Neurol 1992;32:570-576.
  
• Sunder TR. Attention Deficit Disorder: Reductio ad Absurdum. J. Child Neurol 1992;7:454-458.
  
• Davis R, Sunder T, Barakat H, Carpenter J, May R. Valproic Acid Induced Changes in Red Cell Membranes. J. Epilepsy 1993;6:118-121.
  
• May R and Sunder T. Hematologic Manifestations of Long Term Valproate Therapy, Epilepsia 1993;34:1098-1101.
  

  Recent Presentations

• Sunder, TR, Multimodal Functional Model, Annual Convention, ARC of Illinois, Naperville, IL, May, 1995.
• Sunder, TR, Professional as Parents, "Focus on Abilities" Conference, Early Intervention Services, Peoria, IL, May 1995.
• Sunder, TR, Family Centered Treatments: Professional as Parent, State Conference, Illinois Early Intervention Project, November, 1995.
• Sunder, TR, The Myth of ADHD, Southern Illinois University School of Medicine, November 1995.
• Sunder, TR, Ketogenic Diet: An Old idea Resurrected, Statewide Nutrition Conference, Illinois Department of Mental Health and Developmental Disabilities, February, 1996.
• Sunder, TR and Malan R, Medication Effects and Side Effects, Statewide Deaf/Blind Technical Assistance Team Meeting, Illinois Department of Mental Health and Developmental Disabilities, April 1996.
• Sunder, TR, The Neurology of Attention Deficit, Developmental Behavioral Issues: Infancy Through School Age, SIU Centers for Disorders in Development and Learning, and Department of Pediatrics, Springfield, April, 1996.
• Sunder, TR, Epilepsy in Individuals with Multiple Disabilities, Annual Developmental Disabilities Conference, Department of Psychiatry, Southern Illinois University School of Medicine and Illinois Department of Mental Health and Developmental Disabilities, Springfield, June, 1996.

  Grants

  Primary Investigator

• Treatment of Muscle Carnitine Deficiency in Infancy, National Naval Medical Center, Principal Investigator, 1980, in collaboration with W. King Engel, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, 1980-1981.
• Tegretol vs. Phenytoin in Epileptic Children Under Six Years of Age, Associate Investigator, Ciba-Geigy Study # M-3734H, Protocol # 24, with G. Earl Trevathan, M.D., Principal Investigator, 1985.
• A Study of Possible Association of Reye's Syndrome and Aspirin, Site Coordinator, East Carolina University School of Medicine, with Brian Forsyth, M.B., Ch.B., and Ralph Horwitz, M.D., Principal Investigators, Yale University School of Medicine, 1986-1987.
• Parents Supporting Parents Project Grant, Associate Director, Family Support Network and North Carolina Development Disabilities Council, Dewane Frutiger, Project Director, 1987.
• Safety and Efficacy of Conversion to Depakote Monotherapy in Patients with Primary Generalized Seizures, Principal Investigator, Abbott Laboratories, M85-121, 1987.
• Non-Dominant Hemisphere Function, and Learning and Attention Problems in School Age Children, Program Project, Principal Investigator, National Institutes of Health.
• Neurobiologic Basis of Developmental Right Hemisphere Deficit, Principal Investigator, Biomedical Research Support Grant NSS 2 507 RR05812-10, 1989.
• Valproic Acid Alters Membrane Structure and Function, Faculty Advisor to student research project with H.A. Barakat, Ph.D., Department of Biochemistry, 1989.
• Comparison of Safety and Efficacy of Depakote and Carbamazepine in the Treatment of Complex Partial Seizures, Principal Investigator, Abbott Laboratories M86-077, 1989-1990.
• A Multicenter, Placebo-controlled, Parallel Design, Phase III Evaluation of the Safety of Lamotrigine as Add-on Therapy in Outpatients, Principal Investigator, Burroughs-Wellcome Co., Lamotrigine (IND #23,793), Protocol #16, 1989-1990.
• Individual Faculty Scholar Award, Severe Neurobehavioral Difficulties in Infants and Children, Consultant, John Diamond, M.D., Principal Investigator, NIH, 1989-92.
• Muscular Dystrophy Association Clinical Support Grant, Co-Director, East Carolina University School of Medicine and Pitt County Memorial Hospital, 1990.
• Depakote in the Treatment of Complex Partial Seizures, Principal Investigator, Abbott Laboratories M88-194, 1990-1991.
• An Open Study of Lamictal in Epileptic Outpatients, Principal Investigator, Burroughs Wellcome Company, Lamictal (IND #23,793), Protocol #17, 1990.
• Lamotrigine in Partial Seizures in a Child with Intractable Seizures, Principle Investigator, Burroughs-Wellcome Co., Lamictal (IND #35,217), 1990.
• The Safety of Intravenous Valproate, Principal Investigator, Abbott Laboratories M90-540, 1992.
• Compassionate Use of Felbamate in Patients with Epilepsy (Protocol 242C), Principal Investigator, Wallace Laboratories, 1992.
• Compassionate Use of Felbamate in Pediatric Subjects with Epilepsy (Protocol 269B), Principal Investigator, Wallace Laboratories, 1992.
• A Protocol to Provide Lamictal for the Treatment of Serious or Life Threatening Epilepsy (Protocol 26), Principal Investigator, Burroughs Wellcome, 1993.
• Incidence & Prognostic Value of Hippocampal Sclerosis in Children with Temporal Lobe Epilepsy: MRI Study, Collaborator, Darrell Lewis, M.D., Principal Investigator, Duke University Medical Center, National Institutes of Health, 1993-94 (non-funded).
• A Multi-Center, Double-Blind, Active-Control Evaluation of the Efficacy and Safety of Lamotrigine Monotherapy in Patients with Partial Seizures (Protocol 30), Principal Investigator, Burroughs Wellcome Co., 1994.
• A Multicenter, Double-Blind, Placebo-Controlled Parallel-Design Evaluation of Lamictal for Add-on Treatment of Partial Seizures in Pediatric Patients (Protocol 40), Principal Investigator, Burroughs Wellcome Co., 1994.
• Quality of Life Outcomes in Individuals with Developmental Disabilities and Epilepsy, Principal Investigator, Parke-Davis Company, 1995.
  

Site designed and maintained by:
Carolyn Higgason - SIU School of Medicine - Department of Neurology
Last Revised 04/11/2008, Copyright © 2006
Privacy Policy